Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$1.17 0.01 (0.86%)
2/9/2010 4:00 PM

StemCells, Inc. (STEM)

CAPS Rating:
***

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

STEM doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

434 Outperforms
41 Underperforms
 

All-Stars

120 Outperforms
11 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on STEM are also bullish on:

Members bearish on STEM are also bearish on:

Ticker Tags

Healthcare (711), It's a Noun! (69), Defensive (1457), Growth (1902), Micro Cap (4701), Aggressive Growth (860), Biotechnology (220), Stem Cells (3)
Suggest a tag

StemCells, Inc. At A Glance

Current Price: $1.17
Last Trade Time: 2/9/2010 4:00 PM
Open: $1.16
Previous Close: $1.16
Daily Range: $1.12 - $1.18
52-Week Range: $1.02 - $2.64
Volume: 2,017,357
Market Cap: $138.47M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

STEM VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

StemCells, Inc. (STEM)

Avatar jkleiman (52.82) Submitted: 10/05/09 3:36 PM

Hard to value a stock like this. It's a long-term buy. Eventually stem cells will play a huge rule in modern medicine. When is only a matter of time, and Bush or Jesus or any of their pals can always set science back

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

StemCells, Inc. (STEM)

Avatar abitare (99.58) Submitted: 1/27/09 2:08 PM

1. Chart


2. P/E = $0


3. Shadowing some Top Fools


4. Stock dilution


5. $.66 to $2.64 = LOL!


Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 90 :   1 2 3 4 5 Next » Jump to page:

Recs

1

 (STEM)

Avatar jkleiman (52.82) Submitted: 10/05/09 3:36 PM : Outperform Start Price: $1.53 STEM Score: -26.70

Hard to value a stock like this. It's a long-term buy. Eventually stem cells will play a huge rule in modern medicine. When is only a matter of time, and Bush or Jesus or any of their pals can always set science back

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar kingleader (72.53) Submitted: 9/20/09 4:30 AM : Underperform Start Price: $1.75 STEM Score: 34.40

Some interesting trials but treatments are years away.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (STEM)

Avatar 08PortfolioModel (< 20) Submitted: 9/19/09 7:53 PM : Outperform Start Price: $1.64 STEM Score: -30.71

Current 1.74, Sept 18 09. Limit 1.65

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar Fitzcap (< 20) Submitted: 8/28/09 1:58 PM : Outperform Start Price: $1.62 STEM Score: -35.39

Stemcell cures are the wave of of future in medicine and the current administration in in favor of this type of research so they should be Ok for the next 4 years

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (STEM)

Avatar englandstumpy (37.72) Submitted: 8/05/09 1:54 PM : Outperform Start Price: $1.69 STEM Score: -37.82

Obama is infavor of this research and will remove restrictions and possibly add funding.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 90 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackDawsonJames 43.72 01/14/09 Outperform NS $1.62-27.78%+27.57%-55.35

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 156ms